What is Found?
Found is a telehealth weight loss platform that pairs patients with board-certified providers — many specializing in obesity medicine — who prescribe GLP-1 medications and other weight management drugs. Founded in 2019, Found differentiates itself by offering a broader range of medications than most competitors and by emphasizing provider-patient relationships over quick-script efficiency.
How it works
Intake. You complete an online health assessment covering medical history, weight loss goals, current medications, and insurance information. Found uses this to match you with an appropriate provider.
Provider consultation. You get a video visit with a licensed clinician. Found's provider network includes physicians and nurse practitioners, many with obesity medicine board certification. The initial visit typically covers your metabolic profile, medication options, lifestyle factors, and a treatment plan.
Medication. Found prescribes across several drug classes:
- GLP-1 agonists: Semaglutide (compounded and brand),
tirzepatide (compounded and brand)
- Combination therapies: metformin, bupropion/naltrexone
(Contrave), topiramate
- Adjunct medications: based on individual metabolic
profiles
This breadth is a real differentiator. If a GLP-1 isn't right for you — due to cost, contraindications, or side effect intolerance — Found can pivot to alternatives without sending you to a different program.
Ongoing care. Monthly or bimonthly check-ins with your provider. Found also offers a coaching layer with habit change programming, though it's less structured than programs like Calibrate.
Pricing
Found's pricing model has evolved. As of early 2026:
Membership: $99–$149/month depending on plan tier. This covers provider consultations, coaching access, and program support.
Medication: Billed separately. Compounded semaglutide typically runs $150–$250/month through Found's pharmacy partners. Brand-name GLP-1s are routed through insurance where covered. Other medications (metformin, Contrave) are generally much cheaper.
Total self-pay cost: Expect $250–$400/month for membership + compounded GLP-1. Less if you're on non-GLP-1 medications.
Clinical approach
Found's clinical model sits between the quick-script platforms (Hims, Done) and the high-touch programs (Calibrate, Sequence).
Provider quality. Generally strong. Found emphasizes obesity medicine credentials and the provider network includes physicians who treat weight management as a primary specialty, not a side offering. Visits are substantive enough to discuss labs, comorbidities, and medication adjustments in detail.
Multi-drug approach. This is Found's biggest clinical advantage. Rather than being locked into a single medication path, your provider can combine drugs or switch classes based on your response. Some patients do well on a GLP-1 alone; others benefit from adding metformin for insulin resistance or bupropion for food-noise reduction.
Lab integration. Found orders labs when clinically indicated and uses metabolic markers to guide treatment decisions beyond scale weight.
Pros
Medication flexibility. More drug options than almost any competitor. If a GLP-1 doesn't work or isn't affordable, you're not stuck.
Provider quality. Obesity medicine specialists who treat this as their primary focus.
Insurance routing. Found navigates insurance for brand- name GLP-1s and handles prior authorizations.
Reasonable pricing. Membership fees are competitive with the market. Not the cheapest, but strong value given the clinical depth.
Cons
Coaching is secondary. The behavior change programming exists but isn't as structured as Calibrate's year-long curriculum. If you want intensive coaching, Found alone may not be enough.
Variable wait times. Some patients report longer-than- expected waits for initial appointments, particularly in states with fewer providers.
Compounded medication quality varies. Found works with multiple pharmacy partners, and compounded medication consistency can vary between pharmacies — this is a compounding industry issue, not specific to Found.
Who is Found best for?
Found is best for patients who:
- Want a provider with genuine obesity medicine expertise
- May need medication options beyond just GLP-1s
- Have complex metabolic profiles (PCOS, insulin resistance,
depression-related weight gain)
- Want insurance navigation for brand-name drugs
- Prefer a substantive provider relationship at a moderate
price point
Found is less ideal if you:
- Want the cheapest possible path to a GLP-1 prescription
- Primarily want structured coaching and accountability
- Want same-day prescriptions with minimal clinical gatekeeping
Our bottom line
Found occupies a solid middle ground in the GLP-1 telehealth market. The multi-drug clinical model and provider quality give it an edge for patients with complex situations — multiple comorbidities, medication sensitivities, or previous treatment failures. The pricing is competitive without sacrificing clinical substance.
If your weight management needs are straightforward (healthy adult, want semaglutide, cost-sensitive), simpler platforms may suffice. But if you want a provider who can think across multiple drug classes and treat your metabolic profile holistically, Found delivers real value.